NYSE:HIMSHealthcare
Is It Too Early To Reconsider Hims & Hers Health (HIMS) After Recent Share Price Pullback?
If you are wondering whether Hims & Hers Health is reasonably priced at its current level, this article will walk you through what the numbers are actually saying about the stock.
The share price is at US$29.62, with a 7 day return of 5.6% decline, a 30 day return of 14.6% decline, and a year to date move of 11.3% decline. The 1 year return stands at 4.0% decline and the 3 year return is very large.
Recent coverage has focused on how the business model is resonating with consumers in areas...